Kiniksa Pharmaceuticals International, Plc · NASDAQ:KNSA

Megna Michael R exercised options for 3,932 Kiniksa Pharmaceuticals International, Plc shares (Form 4)

Traded Apr 7, 2026 · Filed Apr 8, 2026

On Apr 7, 2026, Megna Michael R (CHIEF ACCOUNTING OFFICER) exercised options for 3,932 Kiniksa Pharmaceuticals International, Plc shares at US$1.00 for US$3,932, leaving 34,043 shares. Filed Apr 8, 2026 (Form 4).

Options exercised
3,932 shares
Price
US$1.00
Value
US$3,932
Holding after
34,043 shares
Trading plan
No
Role
CHIEF ACCOUNTING OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 7, 2026Class A Ordinary ShareOption exercise3,932US$1.0035,709Direct
Apr 7, 2026Class A Ordinary ShareShares withheld for tax1,666US$48.9434,043Direct

Source

View original at SEC

Related